• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DNAM-1 通过在炎症条件下干扰 TIGIT 来调节调节性 T 细胞中 Foxp3 的表达。

DNAM-1 regulates Foxp3 expression in regulatory T cells by interfering with TIGIT under inflammatory conditions.

机构信息

Department of Immunology, Faculty of Medicine, University of Tsukuba, Tsukuba 305-8575, Japan.

Life Science Center for Survival Dynamics, Tsukuba Advanced Research Alliance, University of Tsukuba, Tsukuba 305-8575, Japan.

出版信息

Proc Natl Acad Sci U S A. 2021 May 25;118(21). doi: 10.1073/pnas.2021309118.

DOI:10.1073/pnas.2021309118
PMID:34011606
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8166105/
Abstract

Regulatory T (Treg) cells that express forkhead box P3 (Foxp3) are pivotal for immune tolerance. Although inflammatory mediators cause Foxp3 instability and Treg cell dysfunction, their regulatory mechanisms remain incompletely understood. Here, we show that the transfer of Treg cells deficient in the activating immunoreceptor DNAM-1 ameliorated the development of graft-versus-host disease better than did wild-type Treg cells. We found that DNAM-1 competes with T cell immunoreceptor with Ig and ITIM domains (TIGIT) in binding to their common ligand CD155 and therefore regulates TIGIT signaling to down-regulate Treg cell function without DNAM-1-mediated intracellular signaling. DNAM-1 deficiency augments TIGIT signaling; this subsequently inhibits activation of the protein kinase B-mammalian target of rapamycin complex 1 pathway, resulting in the maintenance of Foxp3 expression and Treg cell function under inflammatory conditions. These findings demonstrate that DNAM-1 regulates Treg cell function via TIGIT signaling and thus, it is a potential molecular target for augmenting Treg function in inflammatory diseases.

摘要

表达叉头框蛋白 P3(Foxp3)的调节性 T(Treg)细胞对于免疫耐受至关重要。尽管炎症介质导致 Foxp3 不稳定和 Treg 细胞功能障碍,但它们的调节机制仍不完全清楚。在这里,我们表明,缺乏激活免疫受体 DNAM-1 的 Treg 细胞的转移比野生型 Treg 细胞更好地改善移植物抗宿主病的发展。我们发现,DNAM-1 与 T 细胞免疫受体 Ig 和 ITIM 结构域(TIGIT)竞争与它们共同配体 CD155 的结合,因此调节 TIGIT 信号转导,以在没有 DNAM-1 介导的细胞内信号转导的情况下下调 Treg 细胞功能。DNAM-1 缺乏会增强 TIGIT 信号转导;这随后抑制蛋白激酶 B-雷帕霉素靶蛋白复合物 1 通路的激活,导致 Foxp3 表达和 Treg 细胞功能在炎症条件下得以维持。这些发现表明,DNAM-1 通过 TIGIT 信号转导调节 Treg 细胞功能,因此它是增强炎症性疾病中 Treg 功能的潜在分子靶标。

相似文献

1
DNAM-1 regulates Foxp3 expression in regulatory T cells by interfering with TIGIT under inflammatory conditions.DNAM-1 通过在炎症条件下干扰 TIGIT 来调节调节性 T 细胞中 Foxp3 的表达。
Proc Natl Acad Sci U S A. 2021 May 25;118(21). doi: 10.1073/pnas.2021309118.
2
DNAM-1 versus TIGIT: competitive roles in tumor immunity and inflammatory responses.DNAM-1 与 TIGIT:在肿瘤免疫和炎症反应中的竞争作用。
Int Immunol. 2021 Nov 25;33(12):687-692. doi: 10.1093/intimm/dxab085.
3
Divergent Phenotypes of Human Regulatory T Cells Expressing the Receptors TIGIT and CD226.表达受体TIGIT和CD226的人类调节性T细胞的不同表型
J Immunol. 2015 Jul 1;195(1):145-55. doi: 10.4049/jimmunol.1402381. Epub 2015 May 20.
4
Tumor Progression Locus 2 (Tpl2) Activates the Mammalian Target of Rapamycin (mTOR) Pathway, Inhibits Forkhead Box P3 (FoxP3) Expression, and Limits Regulatory T Cell (Treg) Immunosuppressive Functions.肿瘤进展位点2(Tpl2)激活雷帕霉素哺乳动物靶标(mTOR)通路,抑制叉头框蛋白P3(FoxP3)表达,并限制调节性T细胞(Treg)的免疫抑制功能。
J Biol Chem. 2016 Aug 5;291(32):16802-15. doi: 10.1074/jbc.M116.718783. Epub 2016 Jun 3.
5
Characteristic of TIGIT and DNAM-1 Expression on Foxp3+ T Cells in AML Patients.AML 患者中 Foxp3+ T 细胞上的 TIGIT 和 DNAM-1 表达的特征。
Biomed Res Int. 2020 Jul 27;2020:4612952. doi: 10.1155/2020/4612952. eCollection 2020.
6
The TIGIT/CD226 axis regulates human T cell function.TIGIT/CD226 轴调节人类 T 细胞功能。
J Immunol. 2012 Apr 15;188(8):3869-75. doi: 10.4049/jimmunol.1103627. Epub 2012 Mar 16.
7
Promoting regulation via the inhibition of DNAM-1 after transplantation.移植后通过抑制 DNAM-1 来促进调控。
Blood. 2013 Apr 25;121(17):3511-20. doi: 10.1182/blood-2012-07-444026. Epub 2013 Feb 21.
8
Role of STAT3 in CD4+CD25+FOXP3+ regulatory lymphocyte generation: implications in graft-versus-host disease and antitumor immunity.信号转导与转录激活因子3(STAT3)在CD4+CD25+FOXP3+调节性淋巴细胞生成中的作用:对移植物抗宿主病和抗肿瘤免疫的影响
J Immunol. 2007 Dec 1;179(11):7593-604. doi: 10.4049/jimmunol.179.11.7593.
9
Helios but not CD226, TIGIT and Foxp3 is a Potential Marker for CD4 Treg Cells in Patients with Rheumatoid Arthritis.Helios而非CD226、TIGIT和Foxp3是类风湿关节炎患者CD4调节性T细胞的潜在标志物。
Cell Physiol Biochem. 2019;52(5):1178-1192. doi: 10.33594/000000080.
10
Essential role of CD155 glycosylation in functional binding to DNAM-1 on natural killer cells.CD155 糖基化在自然杀伤细胞上与 DNAM-1 功能性结合中的必需作用。
Int Immunol. 2024 Apr 27;36(6):317-325. doi: 10.1093/intimm/dxae005.

引用本文的文献

1
The Immune Regulatory Functions of CD226 and Its Implications in Immune-Mediated Diseases.CD226的免疫调节功能及其在免疫介导疾病中的意义。
Biomolecules. 2025 Jul 14;15(7):1007. doi: 10.3390/biom15071007.
2
Tiragolumab and TIGIT: pioneering the next era of cancer immunotherapy.替雷利珠单抗与TIGIT:开创癌症免疫治疗的新时代。
Front Pharmacol. 2025 Jun 11;16:1568664. doi: 10.3389/fphar.2025.1568664. eCollection 2025.
3
Immunotherapy with low-dose IL-2 attenuates vascular injury in mice with diabetic and neovascular retinopathy by restoring the balance between Foxp3 Tregs and CD8 T cells.低剂量白细胞介素-2免疫疗法通过恢复Foxp3调节性T细胞和CD8 T细胞之间的平衡,减轻糖尿病性和新生血管性视网膜病变小鼠的血管损伤。
Diabetologia. 2025 Mar 25. doi: 10.1007/s00125-025-06412-8.
4
Tumor Microenvironment Drives the Cross-Talk Between Co-Stimulatory and Inhibitory Molecules in Tumor-Infiltrating Lymphocytes: Implications for Optimizing Immunotherapy Outcomes.肿瘤微环境驱动肿瘤浸润淋巴细胞中共刺激分子与抑制分子之间的相互作用:对优化免疫治疗结果的启示。
Int J Mol Sci. 2024 Nov 29;25(23):12848. doi: 10.3390/ijms252312848.
5
Revisiting T-cell adhesion molecules as potential targets for cancer immunotherapy: CD226 and CD2.重新审视 T 细胞黏附分子作为癌症免疫治疗的潜在靶点:CD226 和 CD2。
Exp Mol Med. 2024 Oct;56(10):2113-2126. doi: 10.1038/s12276-024-01317-9. Epub 2024 Oct 1.
6
Dysfunction of type 1 and type 2 immune cells: a lesson from exhausted-like ILC2s and their activation-induced cell death.1 型和 2 型免疫细胞功能障碍:耗尽样 ILC2 及其激活诱导的细胞死亡带来的启示。
Int Immunol. 2024 Oct 26;36(11):585-594. doi: 10.1093/intimm/dxae032.
7
TIGIT Regulates T Cell Inflammation in Airway Inflammatory Diseases.TIGIT调节气道炎性疾病中的T细胞炎症。
Inflammation. 2025 Feb;48(1):15-24. doi: 10.1007/s10753-024-02045-y. Epub 2024 May 23.
8
Treg in inborn errors of immunity: gaps, knowns and future perspectives.固有免疫缺陷中的调节性 T 细胞:差距、已知和未来展望。
Front Immunol. 2024 Jan 8;14:1278759. doi: 10.3389/fimmu.2023.1278759. eCollection 2023.
9
TIGIT reverses IFN-α-promoted Th1-like Tregs via in-sequence effects dependent on STAT4.TIGIT 通过依赖于 STAT4 的顺序效应逆转 IFN-α 促进的 Th1 样调节性 T 细胞。
Arthritis Res Ther. 2023 Nov 17;25(1):221. doi: 10.1186/s13075-023-03202-8.
10
Treg-Specific CD226 Deletion Reduces Diabetes Incidence in NOD Mice by Improving Regulatory T-Cell Stability.通过提高调节性T细胞稳定性,Treg特异性CD226缺失降低NOD小鼠的糖尿病发病率。
Diabetes. 2023 Nov 1;72(11):1629-1640. doi: 10.2337/db23-0307.

本文引用的文献

1
Eomes-Dependent Loss of the Co-activating Receptor CD226 Restrains CD8 T Cell Anti-tumor Functions and Limits the Efficacy of Cancer Immunotherapy.Eomes 依赖性共激活受体 CD226 的缺失抑制 CD8 T 细胞的抗肿瘤功能,并限制癌症免疫疗法的疗效。
Immunity. 2020 Oct 13;53(4):824-839.e10. doi: 10.1016/j.immuni.2020.09.006.
2
CD226 Attenuates Treg Proliferation via Akt and Erk Signaling in an EAE Model.CD226 通过 Akt 和 Erk 信号通路在 EAE 模型中抑制调节性 T 细胞增殖。
Front Immunol. 2020 Aug 21;11:1883. doi: 10.3389/fimmu.2020.01883. eCollection 2020.
3
CD226 deficiency on regulatory T cells aggravates renal fibrosis via up-regulation of Th2 cytokines through miR-340.CD226 缺陷导致调节性 T 细胞功能障碍,通过 miR-340 上调 Th2 细胞因子加重肾纤维化。
J Leukoc Biol. 2020 Apr;107(4):573-587. doi: 10.1002/JLB.2MA1119-174RR. Epub 2019 Dec 4.
4
TIGIT signaling restores suppressor function of Th1 Tregs.TIGIT信号传导可恢复Th1调节性T细胞的抑制功能。
JCI Insight. 2019 Feb 7;4(3):e124427. doi: 10.1172/jci.insight.124427.
5
Binding mode of the side-by-side two-IgV molecule CD226/DNAM-1 to its ligand CD155/Necl-5.并排双 IgV 分子 CD226/DNAM-1 与其配体 CD155/Necl-5 的结合模式。
Proc Natl Acad Sci U S A. 2019 Jan 15;116(3):988-996. doi: 10.1073/pnas.1815716116. Epub 2018 Dec 27.
6
CD226 opposes TIGIT to disrupt Tregs in melanoma.CD226 通过拮抗 TIGIT 来破坏黑色素瘤中的 Tregs。
JCI Insight. 2018 Jul 26;3(14). doi: 10.1172/jci.insight.121157.
7
A temporally dynamic autoregulatory transcriptional circuit controls the effector Treg programme.一个时间动态的自调节转录回路控制效应性 Treg 程序。
EMBO J. 2018 Aug 15;37(16). doi: 10.15252/embj.201899013. Epub 2018 Jul 10.
8
Blocking CD226 Promotes Allogeneic Transplant Immune Tolerance and Improves Skin Graft Survival by Increasing the Frequency of Regulatory T Cells in a Murine Model.在小鼠模型中,阻断CD226可通过增加调节性T细胞的频率促进同种异体移植免疫耐受并提高皮肤移植存活率。
Cell Physiol Biochem. 2018;45(6):2338-2350. doi: 10.1159/000488182. Epub 2018 Mar 13.
9
The regulation of immune tolerance by FOXP3.FOXP3对免疫耐受的调节。
Nat Rev Immunol. 2017 Nov;17(11):703-717. doi: 10.1038/nri.2017.75. Epub 2017 Jul 31.
10
The Plasticity and Stability of Regulatory T Cells during Viral-Induced Inflammatory Lesions.病毒诱导的炎症病变过程中调节性T细胞的可塑性与稳定性
J Immunol. 2017 Aug 15;199(4):1342-1352. doi: 10.4049/jimmunol.1700520. Epub 2017 Jul 14.